U.S. Markets closed
  • S&P 500

    4,127.99
    -0.81 (-0.02%)
     
  • Dow 30

    33,745.40
    -55.20 (-0.16%)
     
  • Nasdaq

    13,850.00
    -50.19 (-0.36%)
     
  • Russell 2000

    2,233.78
    -9.69 (-0.43%)
     
  • Crude Oil

    59.81
    +0.11 (+0.18%)
     
  • Gold

    1,732.80
    +0.10 (+0.01%)
     
  • Silver

    24.84
    -0.02 (-0.09%)
     
  • EUR/USD

    1.1919
    +0.0001 (+0.0119%)
     
  • 10-Yr Bond

    1.6750
    +0.0090 (+0.54%)
     
  • Vix

    16.91
    +0.22 (+1.32%)
     
  • GBP/USD

    1.3756
    +0.0013 (+0.0977%)
     
  • USD/JPY

    109.3580
    -0.0180 (-0.0165%)
     
  • BTC-USD

    59,962.72
    +7.02 (+0.01%)
     
  • CMC Crypto 200

    1,288.55
    -6.03 (-0.47%)
     
  • FTSE 100

    6,889.12
    -26.63 (-0.39%)
     
  • Nikkei 225

    29,538.73
    -229.33 (-0.77%)
     

Update: Prestige Consumer Healthcare (NYSE:PBH) Stock Gained 25% In The Last Three Years

  • Oops!
    Something went wrong.
    Please try again later.
Simply Wall St
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.

Buying a low-cost index fund will get you the average market return. But if you invest in individual stocks, some are likely to underperform. For example, the Prestige Consumer Healthcare Inc. (NYSE:PBH) share price return of 25% over three years lags the market return in the same period. Zooming in, the stock is actually down 8.0% in the last year.

View our latest analysis for Prestige Consumer Healthcare

In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

During three years of share price growth, Prestige Consumer Healthcare moved from a loss to profitability. That would generally be considered a positive, so we'd expect the share price to be up.

You can see how EPS has changed over time in the image below (click on the chart to see the exact values).

earnings-per-share-growth
earnings-per-share-growth

We know that Prestige Consumer Healthcare has improved its bottom line lately, but is it going to grow revenue? Check if analysts think Prestige Consumer Healthcare will grow revenue in the future.

A Different Perspective

Investors in Prestige Consumer Healthcare had a tough year, with a total loss of 8.0%, against a market gain of about 27%. Even the share prices of good stocks drop sometimes, but we want to see improvements in the fundamental metrics of a business, before getting too interested. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 2% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 2 warning signs we've spotted with Prestige Consumer Healthcare (including 1 which is potentially serious) .

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.